Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read-outs.
about
Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas.Cell Counting and Viability Assessment of 2D and 3D Cell Cultures: Expected Reliability of the Trypan Blue Assay.Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer Model.Editorial: Methods and advances for systems and synthetic biology, nanobiotech and medicine.In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.Engineering principles for guiding spheroid function in the regeneration of bone, cartilage, and skin.A deep conical agarose microwell array for adhesion independent three-dimensional cell culture and dynamic volume measurement.Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis.Development of a Novel 3D Tumor-tissue Invasion Model for High-throughput, High-content Phenotypic Drug Screening
P2860
Q38696894-49E5B730-0E1F-45D5-9A88-02F62EFC9B67Q41065699-9A693A4D-9656-4CF2-8D2F-1C66A7FAFFE0Q42621191-ED3DC0D5-A6D1-4625-B1E4-7D11853F3B39Q46434161-4F9FFAD5-F2AE-485C-984F-49CB7243FDE8Q47119905-9DE9FA69-C787-4855-A55E-FD5BE27E9DCAQ49819256-72F20F15-8A5B-46D2-ABBF-BE51A1337A50Q50052039-1AFB6B43-5C27-4F38-84DF-10E4C60274C3Q52672873-6B2E483F-89C0-4622-9022-A70E6E1CBE07Q58695399-6F7A4A59-EEAF-4C76-B4E4-7BDE13A730A4
P2860
Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read-outs.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Drug screening in 3D in vitro ...... itfalls of efficacy read-outs.
@en
type
label
Drug screening in 3D in vitro ...... itfalls of efficacy read-outs.
@en
prefLabel
Drug screening in 3D in vitro ...... itfalls of efficacy read-outs.
@en
P50
P356
P1476
Drug screening in 3D in vitro ...... itfalls of efficacy read-outs.
@en
P2093
Erwin Boghaert
P356
10.1002/BIOT.201600505
P577
2016-12-14T00:00:00Z